Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 99 Total
MCRP - Micropolis Holding Co - Stock Price Chart
TickerMCRP [AMEX]
CompanyMicropolis Holding Co
CountryUnited Arab Emirates
IndustrySoftware - Infrastructure
Market Cap132.30MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q27.90%
Dividend-Sales Q/Q-
Insider Own77.36%Inst Own-
Insider Trans0.00%Inst Trans0.00%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume946.46K52W Range2.31 - 4.42
Micropolis Holding Co. engages in the development of autonomous mobile robots and related software. It specializes in autonomous mobile robots (AMRs) that utilize wheeled electric vehicle platforms and are equipped with autonomous driving capabilities. The company was founded by Fareed Aljawhari in 2014 and is headquartered Dubai, United Arab Emirates.
RGC - Regencell Bioscience Holdings Ltd - Stock Price Chart
TickerRGC [NASD]
CompanyRegencell Bioscience Holdings Ltd
CountryHong Kong
IndustryDrug Manufacturers - Specialty & Generic
Market Cap164.22MEPS (ttm)-0.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-60.65%
P/S-EPS next 5Y-
P/B19.98EPS Q/Q15.45%
Dividend-Sales Q/Q-
Insider Own88.82%Inst Own0.24%
Insider Trans0.00%Inst Trans56.54%
Short Float0.27%Earnings-
Analyst Recom-Target Price-
Avg Volume412.55K52W Range3.03 - 32.44
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
ECOR - ElectroCore Inc - Stock Price Chart
TickerECOR [NASD]
CompanyElectroCore Inc
CountryUSA
IndustryMedical Devices
Market Cap61.57MEPS (ttm)-1.82
P/E-EPS this Y25.79%
Forward P/E95.11EPS next Y107.63%
PEG-EPS past 5Y28.11%
P/S2.64EPS next 5Y-
P/B5.89EPS Q/Q54.51%
Dividend-Sales Q/Q45.39%
Insider Own20.24%Inst Own16.11%
Insider Trans0.00%Inst Trans-11.35%
Short Float2.12%EarningsMar 12/a
Analyst Recom1.00Target Price25.20
Avg Volume145.43K52W Range5.32 - 19.49
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Errico Thomas J.DirectorAug 15 '24Buy6.125,00030,595233,818Aug 19 09:37 AM
GANDOLFO JOHN PDirectorJun 13 '24Buy6.431,0006,43050,704Jun 17 04:05 PM
Goldberger Daniel SChief Executive OfficerJun 05 '24Buy6.4338,505247,587249,565Jun 06 08:30 AM
MGIH - Millennium Group International Holdings Ltd - Stock Price Chart
TickerMGIH [NASD]
CompanyMillennium Group International Holdings Ltd
CountryHong Kong
IndustryPackaging & Containers
Market Cap18.56MEPS (ttm)-0.78
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.48EPS next 5Y-
P/B0.60EPS Q/Q-495.91%
Dividend-Sales Q/Q-23.61%
Insider Own88.89%Inst Own0.12%
Insider Trans0.00%Inst Trans-45.87%
Short Float5.18%Earnings-
Analyst Recom-Target Price-
Avg Volume1.73M52W Range1.19 - 6.83
Millennium Group International Holdings Ltd. is a paper-based packaging solutions supplier, which engages in the business of production and sale of packaging products and corrugated products. Its integrated business processes include market research, research and development, packaging design and development, raw materials procurement, color management, product testing, quality control and delivery services. The company was founded by Yee Cheong Lai in 1978 and is headquartered in Hong Kong.
DOMH - Dominari Holdings Inc - Stock Price Chart
TickerDOMH [NASD]
CompanyDominari Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap67.80MEPS (ttm)-3.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.39EPS next 5Y-
P/B0.77EPS Q/Q-0.45%
Dividend-Sales Q/Q319.83%
Insider Own44.90%Inst Own3.31%
Insider Trans0.00%Inst Trans2.80%
Short Float3.80%Earnings-
Analyst Recom1.00Target Price16.00
Avg Volume1.76M52W Range0.79 - 13.05
Dominari Holdings, Inc. engages in wealth management, investment banking, sales and trading, and asset management through its subsidiaries. It operates through the Dominari Financial and Legacy AIkido business segments. The Dominari Financial segment represents the company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido segment includes Aikido Labs, which manages the investments holdings of the legacy entity. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayes AnthonyCEOMay 30 '24Buy2.403,4828,357223,146May 31 04:05 PM
Hayes AnthonyCEOMay 29 '24Buy2.251,1582,606219,664May 31 04:05 PM
Wool Kyle MichaelPresidentMay 29 '24Buy2.205,00011,00027,750May 31 04:05 PM
Wool Kyle MichaelPresidentApr 08 '24Buy2.998,50025,39022,750Apr 10 04:10 PM
Wool Kyle MichaelPresidentApr 04 '24Buy2.8719,00054,51118,500Apr 08 04:10 PM
RAIL - FreightCar America Inc - Stock Price Chart
TickerRAIL [NASD]
CompanyFreightCar America Inc
CountryUSA
IndustryRailroads
Market Cap125.42MEPS (ttm)-3.14
P/E-EPS this Y296.67%
Forward P/E8.83EPS next Y25.21%
PEG-EPS past 5Y12.49%
P/S0.22EPS next 5Y64.69%
P/B-EPS Q/Q455.60%
Dividend-Sales Q/Q8.76%
Insider Own24.73%Inst Own42.17%
Insider Trans0.37%Inst Trans24.57%
Short Float2.89%EarningsMar 12/a
Analyst Recom1.00Target Price14.25
Avg Volume218.60K52W Range3.02 - 16.10
FreightCar America, Inc. engages in the manufacture of railcars and railcar components. It operates through the Manufacturing and Corporate and Other segments. The Manufacturing segment includes new railcar manufacturing, used railcar sales, railcar leasing and major railcar rebuilds. The Corporate and Other segment focuses on the sales of parts. The company was founded in 1901 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Josephson GregoryCTO and VP of EngineeringDec 17 '24Proposed Sale10.2025,000255,000Dec 16 11:33 AM
Meyer James RDirectorNov 14 '24Buy10.7423,400251,316838,278Nov 18 05:15 PM
De Nigris Felan JoseDirectorSep 27 '24Buy10.194,00040,74173,147Sep 27 05:27 PM
GEHL WILLIAM DDirectorSep 17 '24Sale10.8310,000108,300147,608Sep 17 05:49 PM
Perez CeliaGC and Corp SecretarySep 12 '24Option Exercise4.481,0004,48043,580Sep 16 04:55 PM
TCX - Tucows, Inc - Stock Price Chart
TickerTCX [NASD, RUT]
CompanyTucows, Inc
CountryCanada
IndustrySoftware - Infrastructure
Market Cap189.76MEPS (ttm)-10.26
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.52EPS next 5Y-
P/B-EPS Q/Q-91.72%
Dividend-Sales Q/Q7.06%
Insider Own20.50%Inst Own58.32%
Insider Trans-2.02%Inst Trans-2.54%
Short Float9.49%EarningsFeb 13/a
Analyst Recom1.00Target Price66.79
Avg Volume37.17K52W Range14.50 - 26.48
Tucows, Inc. is an Internet services company. The firm engages in the provision of domain names, email and other internet services. It operates through the following segments: Ting, Wavelo, and Tucows Domains. The Ting segment its wholly owned subsidiaries, Cedar and Simply Bits includes the provision of high-speed Internet access services to select towns throughout the United States, with further expansion underway to both new and existing markets. The Wavelo segmnet includes the provision of full-service platforms and professional services providing a variety of solutions that support Communication Services providers (CSPs), including subscription and billing management, network orchestration and provisioning, and individual developer tools. The Tucows Domains segment includes wholesale and retail domain name registration services, as well as value added services derived through OpenSRS, eNom, Ascio, EPAG and Hover brands. The company was founded in November 1992 and is headquartered in Toronto, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NOSS ELLIOTChief Executive OfficerFeb 14 '25Sale17.257,760133,879470,198Feb 18 08:27 PM
NOSS ELLIOTChief Executive OfficerFeb 06 '25Sale15.765007,880477,958Feb 06 04:25 PM
NOSS ELLIOTChief Executive OfficerFeb 04 '25Sale15.665007,830478,758Feb 06 04:25 PM
NOSS ELLIOTChief Executive OfficerFeb 05 '25Sale15.683004,704478,458Feb 06 04:25 PM
NOSS ELLIOTChief Executive OfficerJan 27 '25Sale17.121001,712479,258Jan 29 04:37 PM
ADAG - Adagene Inc ADR - Stock Price Chart
TickerADAG [NASD]
CompanyAdagene Inc ADR
CountryChina
IndustryBiotechnology
Market Cap78.42MEPS (ttm)-0.73
P/E-EPS this Y-94.29%
Forward P/E-EPS next Y-30.88%
PEG-EPS past 5Y-5.97%
P/S94.48EPS next 5Y-
P/B1.39EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own24.10%Inst Own8.54%
Insider Trans0.00%Inst Trans20.51%
Short Float0.05%Earnings-
Analyst Recom2.00Target Price8.00
Avg Volume68.05K52W Range1.64 - 3.58
Mar-13-25 08:00AM Adagene to Present at 11th Annual Immuno-Oncology 360 Summit (GlobeNewswire)
Mar-06-25 08:00AM Adagene to Present at Leerink's Global Healthcare Conference 2025 (GlobeNewswire)
Feb-27-25 08:00AM Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer (GlobeNewswire)
Jan-27-25 07:00AM Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium (GlobeNewswire)
Jan-21-25 05:00PM Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium (GlobeNewswire)
Jan-14-25 08:00AM Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025 (GlobeNewswire)
Jan-08-25 09:40AM Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? (Zacks) -5.34%
Dec-06-24 09:40AM Are Medical Stocks Lagging Adagene (ADAG) This Year? (Zacks)
Nov-20-24 09:40AM Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? (Zacks) -5.86%
Nov-07-24 10:01AM Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting (GlobeNewswire)
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
ESLA - Estrella Immunopharma Inc - Stock Price Chart
TickerESLA [NASD]
CompanyEstrella Immunopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap33.28MEPS (ttm)-0.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B43.40EPS Q/Q94.75%
Dividend-Sales Q/Q-
Insider Own72.09%Inst Own0.81%
Insider Trans0.00%Inst Trans46.75%
Short Float0.22%EarningsFeb 26
Analyst Recom1.00Target Price16.00
Avg Volume60.05K52W Range0.63 - 3.23
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
AMIX - Autonomix Medical Inc - Stock Price Chart
TickerAMIX [NASD]
CompanyAutonomix Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap4.56MEPS (ttm)-12.53
P/E-EPS this Y85.87%
Forward P/E-EPS next Y-267.61%
PEG-EPS past 5Y-
P/S-EPS next 5Y20.29%
P/B0.47EPS Q/Q55.80%
Dividend-Sales Q/Q-
Insider Own21.32%Inst Own19.88%
Insider Trans0.00%Inst Trans348.88%
Short Float3.91%EarningsFeb 26
Analyst Recom1.00Target Price18.00
Avg Volume367.31K52W Range2.03 - 82.00
Mar-14-25 08:30AM Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation (GlobeNewswire) -9.76%
Mar-06-25 09:00AM Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (GlobeNewswire)
Feb-26-25 09:00AM Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit (GlobeNewswire)
Feb-20-25 08:30AM Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting (GlobeNewswire)
Feb-19-25 09:00AM Autonomix Medical, Inc. Participates in the Virtual Investor Top 5 for '25 On-Demand Conference (GlobeNewswire)
Feb-13-25 08:00AM Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jan-24-25 08:45AM Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Jan-17-25 08:00AM Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) +9.79%
Jan-15-25 08:30AM Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +10.55%
Jan-13-25 08:30AM Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting (GlobeNewswire) -8.65%
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in Doylestown, PA.
12345678910